Found 88 matching trials
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
KORTUC (KRC-01) Plus Radiotherapy for Organ Preservation in Rectal Cancer PHASE2 This phase II clinical trial is evaluating whether adding KRC-01 injections...
Show More Learn More & Join Trial
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML PHASE3 MRD driven study. Addition of gemtuzumab to conventional chemotherapy to re...
Show More Location
A.O. - SS. Antonio e Biagio e Cesare Arrigo - SC Ematologia
Learn More & Join Trial
Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer N/A This is a multicenter, randomized, controlled phase III trial to evaluate t...
Show More Location
Department of Radiation Oncology, Shandong Cancer Hospital and Institute
Learn More & Join Trial
Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008 NA QUESTIONS AND OBJECTIVES OF ALL-MB-2008 STUDY
1. Whether the early PEG-asp...
Show More Location
Republican Research and Practical Center of Radiation Medicine
Learn More & Join Trial
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia PHASE1 This study will test if adding ruxolitinib to standard multi-drug chemother...
Show More Location
University of Chicago Medical Center
Learn More & Join Trial
Velcade (Bortezomib) Consolidation After Transplant PHASE3 The purpose of this study is to determine if bortezomib when added to conso...
Show More Location
Multiple Locations
Learn More & Join Trial
UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy PHASE3 This study has been designed to evaluate whether "anti-angiogenesis" therap...
Show More Location
University of Arkansas for Medical Sciences/MIRT
Learn More & Join Trial
DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation PHASE3 The purpose of this study is to find out if transplant with a new regimen o...
Show More Location
University of Arkansas for Medical Sciences/MIRT
Learn More & Join Trial
Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02 PHASE3 This phase III trial is designed to explore a higher radiation dose by usin...
Show More Location
Department of Radiation Oncology, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC)
Learn More & Join Trial